506 related articles for article (PubMed ID: 26998818)
1. Population attributable fractions of risk factors for hepatocellular carcinoma in the United States.
Makarova-Rusher OV; Altekruse SF; McNeel TS; Ulahannan S; Duffy AG; Graubard BI; Greten TF; McGlynn KA
Cancer; 2016 Jun; 122(11):1757-65. PubMed ID: 26998818
[TBL] [Abstract][Full Text] [Related]
2. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.
Welzel TM; Graubard BI; Quraishi S; Zeuzem S; Davila JA; El-Serag HB; McGlynn KA
Am J Gastroenterol; 2013 Aug; 108(8):1314-21. PubMed ID: 23752878
[TBL] [Abstract][Full Text] [Related]
3. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
4. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.
Tagger A; Donato F; Ribero ML; Chiesa R; Portera G; Gelatti U; Albertini A; Fasola M; Boffetta P; Nardi G
Int J Cancer; 1999 May; 81(5):695-9. PubMed ID: 10328218
[TBL] [Abstract][Full Text] [Related]
5. Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013.
Shiels MS; Engels EA; Yanik EL; McGlynn KA; Pfeiffer RM; O'Brien TR
Cancer; 2019 Aug; 125(15):2621-2630. PubMed ID: 30980394
[TBL] [Abstract][Full Text] [Related]
6. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy.
Franceschi S; Montella M; Polesel J; La Vecchia C; Crispo A; Dal Maso L; Casarin P; Izzo F; Tommasi LG; Chemin I; Trépo C; Crovatto M; Talamini R
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):683-9. PubMed ID: 16614109
[TBL] [Abstract][Full Text] [Related]
8. Fifteen-year population attributable fractions and causal pies of risk factors for newly developed hepatocellular carcinomas in 11,801 men in Taiwan.
Liao SF; Yang HI; Lee MH; Chen CJ; Lee WC
PLoS One; 2012; 7(4):e34779. PubMed ID: 22506050
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study.
Trichopoulos D; Bamia C; Lagiou P; Fedirko V; Trepo E; Jenab M; Pischon T; Nöthlings U; Overved K; Tjønneland A; Outzen M; Clavel-Chapelon F; Kaaks R; Lukanova A; Boeing H; Aleksandrova K; Benetou V; Zylis D; Palli D; Pala V; Panico S; Tumino R; Sacerdote C; Bueno-De-Mesquita HB; Van Kranen HJ; Peeters PH; Lund E; Quirós JR; González CA; Sanchez Perez MJ; Navarro C; Dorronsoro M; Barricarte A; Lindkvist B; Regnér S; Werner M; Hallmans G; Khaw KT; Wareham N; Key T; Romieu I; Chuang SC; Murphy N; Boffetta P; Trichopoulou A; Riboli E
J Natl Cancer Inst; 2011 Nov; 103(22):1686-95. PubMed ID: 22021666
[TBL] [Abstract][Full Text] [Related]
10. Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma.
Jeng JE; Tsai HR; Chuang LY; Tsai JF; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Chang JG
Medicine (Baltimore); 2009 Nov; 88(6):349-357. PubMed ID: 19910749
[TBL] [Abstract][Full Text] [Related]
11. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
El-Serag HB; Richardson PA; Everhart JE
Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
[TBL] [Abstract][Full Text] [Related]
12. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
Chiesa R; Donato F; Tagger A; Favret M; Ribero ML; Nardi G; Gelatti U; Bucella E; Tomasi E; Portolani N; Bonetti M; Bettini L; Pelizzari G; Salmi A; Savio A; Garatti M; Callea F
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484
[TBL] [Abstract][Full Text] [Related]
13. Aflatoxin B
Chu YJ; Yang HI; Wu HC; Lee MH; Liu J; Wang LY; Lu SN; Jen CL; You SL; Santella RM; Chen CJ
Eur J Cancer; 2018 May; 94():37-46. PubMed ID: 29533866
[TBL] [Abstract][Full Text] [Related]
14. Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma.
Ohishi W; Fujiwara S; Cologne JB; Suzuki G; Akahoshi M; Nishi N; Tsuge M; Chayama K
Hepatology; 2011 Apr; 53(4):1237-45. PubMed ID: 21480328
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma: recent trends in the United States.
El-Serag HB
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S27-34. PubMed ID: 15508094
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study.
Davila JA; Morgan RO; Shaib Y; McGlynn KA; El-Serag HB
Gastroenterology; 2004 Nov; 127(5):1372-80. PubMed ID: 15521006
[TBL] [Abstract][Full Text] [Related]
17. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
[TBL] [Abstract][Full Text] [Related]
18. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma.
Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH
J Med Virol; 1994 Sep; 44(1):92-5. PubMed ID: 7528262
[TBL] [Abstract][Full Text] [Related]
19. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
20. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort.
Setiawan VW; Wei PC; Hernandez BY; Lu SC; Monroe KR; Le Marchand L; Yuan JM
Cancer; 2016 May; 122(9):1444-52. PubMed ID: 26916271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
